
potent ATP-competitive mTOR inhibitor with an IC50 of about 9 nM. It target of rapamycin (mTOR) is centrally involved in cell growth, has significant selectivity against mTOR over phosphatidylinositol (>100-fold). WAY-600 treated HEK293 cells indicated a 50% inhibition of with the 11% suppression by rapamycin. Unlike the rapalogs,WAY-600 mTORC2-dependent phosphorylation of AKT in vitro and in vivo. In